Cardioprotection by remote ischemic preconditioning exhibits a signaling pattern different from local ischemic...

Area of Science:

• Cardiology
• Physiology
• Molecular Biology

Background:

• Myocardial ischemia/reperfusion (I/R) injury is a significant clinical concern.
• Ischemic preconditioning (IPC) and remote ischemic preconditioning (RIPC) are known protective strategies.
• The underlying molecular mechanisms, particularly the role of protein kinase C (PKC) and mitogen-activated protein kinases (MAPKs), require further elucidation.

Purpose of the Study:

• To characterize the protective effects of early RIPC, IPC, and their combination (RIPC-IPC) against myocardial I/R injury.
• To investigate whether RIPC activates the PKC and MAPK signaling pathways, which are known mediators of IPC.

Main Methods:

• Animals underwent RIPC, IPC, or RIPC-IPC protocols before 35 minutes of regional ischemia and 120 minutes of reperfusion.
• Infarct size, serum troponin T, and creatine kinase levels were measured.
• PKCε and MAPKs (ERK, JNK, p38) were analyzed in myocardial and skeletal muscle tissue via Western blot and activity assays.

Main Results:

• RIPC, IPC, and RIPC-IPC significantly reduced myocardial infarct size and troponin T release compared to I/R alone.
• IPC induced activation of PKCε and ERK1/2 in the myocardium.
• RIPC did not lead to PKCε translocation or MAPK phosphorylation in either myocardium or skeletal muscle.

Conclusions:

• Early RIPC, IPC, and RIPC-IPC provide protection against myocardial I/R injury.
• RIPC and IPC exhibit distinct activation patterns of signaling molecules.
• The PKC-MAPK pathway is unlikely to mediate the protective effects of RIPC.